Aerosol-focused biotech startup Respira Technologies is gearing up for the start of its first human clinical trials and has appointed Brian Quigley as the new chief executive to lead the company through this important phase. Quigley...

LOS ANGELES–(BUSINESS WIRE)–Respira Technologies, Inc.—a clinical-stage company developing inhaled therapeutics for smoking cessation and drug delivery technologies to treat cardiopulmonary diseases—has rebranded as “QNOVIA”...

How do you deal with a problem like Respira? For this health tech company, which must compete with so many similarly named companies and drugs, the remedy is simple: out with the old, and in with the new. And that new name—in what would be...

LOS ANGELES–(BUSINESS WIRE)–Qnovia, Inc. (Qnovia), a pharma company developing inhaled therapeutics with an initial focus on nicotine replacement therapy (NRT) and cardiopulmonary diseases, today announced it has raised $17...